Second-line treatment of small-cell lung cancer with the camptothecin-derivative GI147211: A study of the EORTC Early Clinical Studies Group (ECSG)

Autor: Sessa, C. *, Wanders, J., Roelvink, M., Dombernowsky, P., Nielsen, D., Morant, R., Drings, P., Wissel, P., Hanauske, A.-R.
Zdroj: In Annals of Oncology February 2000 11(2):207-210
Databáze: ScienceDirect